home / stock / adilw / adilw news

ADILW News and Press, Adial Pharmaceuticals Inc Warrant From 06/13/19

Stock Information
Company Name: Adial Pharmaceuticals Inc Warrant
Stock Symbol: ADILW
Market: NASDAQ
Website: adialpharma.com
Menu
ADILW ADILW Quote ADILW Short ADILW News ADILW Articles ADILW Message Board
Get ADILW Alerts

News, Short Squeeze, Breakout and More Instantly...
ADILW - Adial Pharmaceuticals Receives Notification Prior to Acceptance of Israeli Patent for AD04 in Alcohol Use Disorder

CHARLOTTESVILLE, VA / ACCESSWIRE / June 13, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced the further strengthening of its intellectual property (IP) portfolio, as i...
ADILW - Adial Pharmaceuticals and Tedor Pharma Announce Collaboration to Manufacture AD04 Through Commercialization

Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 CHARLOTTESVILLE, VA / ACCESSWIRE / June 6, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, an...

ADILW - Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder

CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has entered into a collaboration agreement with ...

ADILW - Adial Pharmaceuticals CEO to Present at the ThinkEquity Conference on May 2nd in New York City

CHARLOTTESVILLE, VA / ACCESSWIRE / April 30 , 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced William Stilley, President and Chief Executive Officer, is scheduled ...
ADILW - Adial Pharmaceutical's Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate

World-renowned addiction doctor talks about combating alcohol and opioid addiction during National Alcohol Awareness Month CHARLOTTESVILLE, VA / ACCESSWIRE / April 22 , 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on t...

ADILW - Adial Pharmaceuticals Announces Appointment of Alex Lugovoy as Head of Strategy

Adial to Advance Corporate Partnerships; Licensing and M&A Opportunities CHARLOTTESVILLE, VA / ACCESSWIRE / April 11, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, t...

ADILW - Bankole A. Johnson, M.D., Chief Medical Officer of Adial Pharmaceuticals Delivers Keynote Lecture; Receives Prestigious American Society of Addiction Medicine Award

Lecture to focus on pharmacogenic treatment personalization for alcohol use disorder CHARLOTTESVILLE, VA / ACCESSWIRE / April 4, 2019 / Adial Pharmaceuticals Inc. , (NADSAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction,...
ADILW - Adial Pharmaceuticals Announces Open Market Purchases of Common Stock by Chief Medical Officer, Bankole Johnson, M.D.

CHARLOTTESVILLE, VA / ACCESSWIRE / April 3, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that Bankole A. Johnson, M.D., DSc., M.B., ChB., M.Phil., DFAPA, FRCPsych,...

ADILW - Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer

CHARLOTTESVILLE, VA / ACCESSWIRE / March 26, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; NASDAQ: ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that Bankole A. Johnson, M.D., DSc., M.B., ChB., M.Phil., DFAPA...

ADILW - Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants

CHARLOTTESVILLE, VA / ACCESSWIRE / March 25, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, announced today that it filed a Registration Statement on Form S-1 on March 22, 2019, to ...
Previous 10 Next 10